许敏,吴晓云,李勇刚,等.CITED2基因CpG岛甲基化与先天性心脏病的关系[J].第三军医大学学报,2013,35(03):245. Xu Min,Wu Xiaoyun,Li Yonggang,et al.Relationship of CpG islands methylation of CITED2 and congenital heart disease[J].J Third Mil Med Univ,2013,35(04):245. [2]钟理,宋治远,冉擘力,等.先天性巨大冠状动脉右室瘘的介入治疗[J].第三军医大学学报,2008,30(04):348. ZHONG Li,SONG Zhi-yuan,RAN Bo-li,et al.Transcatheter closure of giant congenital coronary artery fistula with patent duct occluder[J].J Third Mil Med Univ,2008,30(04):348. [3]徐红珍,杨利群,叶茂,等.5 kg以下婴儿先天性心脏病体外循环管理[J].第三军医大学学报,2006,28(05):478. [4]杨静,宋晓英,张羽,等.狼疮相关性肺动脉高压的临床研究[J].第三军医大学学报,2007,29(03):273. [5]李志平,范士志,蒋耀光,等.风心病合并肺动脉高压体外循环后前列腺素E1抵抗现象的研究[J].第三军医大学学报,2007,29(09):792. LI Zhi-ping,FAN Shi-zhi,JIANG Yao-guang,et al.Resistance to prostaglandin E1 in postoperative early stage of valvular replacement in rheumatic heart disease patients[J].J Third Mil Med Univ,2007,29(04):792. [6]舒茂琴,宋治远,钟理,等.动脉导管未闭合并感染性心内膜炎的介入治疗[J].第三军医大学学报,2006,28(13):1432. [7]杨望,廖伟,赵聪敏.西地那非治疗婴幼儿先天性心脏病重度肺动脉高压疗效观察[J].第三军医大学学报,2011,33(15):1623. Yang Wang,Liao Wei,Zhao Congmin.Therapeutic effect of sildenafil on severe pulmonary arterial hypertension associated with congenital heart disease in infants[J].J Third Mil Med Univ,2011,33(04):1623. [8]刘铭,杨康,曾会昌,等.46例成人继发孔房间隔缺损合并肺动脉高压的外科治疗经验[J].第三军医大学学报,2005,27(24):2464. [9]徐效龙,祁国荣,王黎明,等.12例覆膜支架治疗高原巨大动脉导管未闭伴重度肺动脉高压的近期疗效分析[J].第三军医大学学报,2013,35(06):579. [10]张智睿,陈沅,向平,等.血清NT-proBNP在青紫型先天性心脏病患儿中的临床意义[J].第三军医大学学报,2010,32(17):1880. Zhang Zhirui,Chen Yuan,Xiang Ping,et al.Clinical significance of serum N-terminal pro-brain natriuretic peptide in children with cyanotic congenital heart disease[J].J Third Mil Med Univ,2010,32(04):1880. [11]唐旭东,肖颖彬,周建国,等.Survivin在先天性心脏病肺动脉高压发生机制中的作用[J].第三军医大学学报,2008,30(01):27. TANG Xu-dong,XIAO Ying-bin,ZHOU Jian-guo,et al.Role of survivin in pulmonary hypertension of congenital heart disease[J].J Third Mil Med Univ,2008,30(04):27.
